Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neuroblastoma × Pharmaceutical Preparations × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Glioblastoma 1 Drug-Related Side Effects and Adverse Reactions 1 Depression 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Anxiety Disorders 1 All Solid Tumors 1

Interventions

Temozolomide 10 Irinotecan 8 Cyclophosphamide 7 dinutuximab 5 aldesleukin 4 Interleukin-2 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 sargramostim 3 fludarabine 3 Topotecan 3 Melphalan 3 Isotretinoin 3 Filgrastim 3 gallium Ga 68 dotatate 2 Vincristine 2 TPI-287 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Carboplatin 2 venetoclax 1 trametinib 1 thymoglobulin 1 talazoparib 1 sonidegib 1 silmitasertib 1 plerixafor 1 olaparib 1 naxitamab 1 lutetium Lu 177 dotatate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07334301 2026-01-12

BEACON2

University of Birmingham

Phase 1/2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡